<DOC>
	<DOCNO>NCT00133848</DOCNO>
	<brief_summary>The goal study determine topical SB-275833 ointment , 1 % effective placebo ointment treatment primary impetigo .</brief_summary>
	<brief_title>Treatment Of Impetigo With Topical SB-275833 Ointment , 1 % Versus Topical Placebo Ointment</brief_title>
	<detailed_description />
	<mesh_term>Impetigo</mesh_term>
	<criteria>Inclusion criterion : Must primary impetigo total lesion area 100 square centimeter less . Women could bear child must negative urine pregnancy test agree either abstain sexual intercourse use specific effective contraceptive measure . Any sign symptom systemic infection . Any serious underlying disease could imminently life threatening .</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>impetigo</keyword>
	<keyword>topical antibacterial</keyword>
	<keyword>topical antibiotic</keyword>
</DOC>